A. Campbell Sullivan, a neuropsychologist, discovered a gap between treatment and science of ALS and dementia in her own family. She notes that advances in genetics and biomarker discovery are transforming research and care in ALS and FTD.
The University of Texas at San Antonio School of Nursing has earned a second prestigious Center of Excellence designation in nursing education, recognizing its commitment to advancing innovative approaches to nursing education and student success. The school is one of only 19 nursing education programs nationwide to receive this design...
Dr. Georg Aue, a nationally recognized blood cancer expert, has been named the inaugural director of the Stem Cell Transplant and Cellular Therapy Program at UT Health San Antonio. The program aims to increase access to new therapeutic approaches for patients across South Texas, with a focus on clinical excellence, research innovation,...
Researchers at UT Health San Antonio have uncovered how the liver's internal clock coordinates the release of proteins that regulate metabolism. The findings suggest that understanding this internal clock could help guide future research on metabolic disease and inform optimal timing for meals and medication.
A new study from UT Health San Antonio found that any degree of physical activity can slow cognitive decline in Hispanics. The research, which included 402 participants, also showed that controlling blood sugar levels and cardiovascular health are associated with a slower rate of cognitive decline.
A new study from UT Health San Antonio found that Hispanic populations experience higher rates of frontotemporal dementia, with significant delays in diagnosis due to educational disparities. The research highlights the importance of culturally sensitive diagnostic tools and interventions for equitable dementia care.
The Biggs Institute is leading a $2.5 million national, multi-site study to improve detection and diagnosis of dementia with Lewy bodies. The study will enroll 125 participants and evaluate multiple possible new tools and methods to accurately identify individuals who have accumulated abnormal alpha-synuclein in the brain.
A new study from UT Health San Antonio found a link between long sleep hours and higher levels of an Alzheimer's-related protein in the blood. The research suggests that long sleep may reflect early neurodegenerative processes, but more sleep is not always better for brain health.
Amelie G. Ramirez is studying the impact of therapeutic yoga on health-related quality of life, fatigue and physical function in Hispanic breast cancer survivors. She aims to find culturally responsive ways to support recovery through a comparison of standard physical therapy and therapeutic yoga.
Researchers at UT Health San Antonio found a link between the bacterium Faecalibacterium prausnitzii and systemic lupus erythematosus. Supplementation with this bacteria reduced markers of the disease in animal models, showing promise for treatment.
The PediQEESI is a new pediatric adaptation of the QEESI questionnaire to assess chemical intolerance in children. It can help identify patterns among symptoms, exposures, and daily functioning, enabling parents and clinicians to avoid future exposure and trigger symptoms.
The University of Texas at San Antonio Health Science Center has received a grant from the American Cancer Society to implement HPV self-collection in primary care settings. The pilot aims to make cervical cancer screening more accessible for patients who face barriers to traditional screening.
The University of Texas at San Antonio has received significant funding from the Cancer Prevention and Research Institute of Texas to develop innovative cancer research technologies and treatments. The institution will focus on pressing cancers such as Ewing sarcoma, obesity-related endometrial cancer risk, and AI in clinical oncology.
The RURAL Cohort Study aims to understand why residents of rural communities experience higher rates of heart, lung, and blood-related diseases, as well as shorter life expectancy and less-than-optimal overall health outcomes. The study uses a custom-built mobile examination unit to bring research directly to the community doorstep.
Researchers investigate how environmental stressors like jet lag and high-fat diets affect Alzheimer's risk. They aim to determine if restoring metabolic rhythms can prevent the progression of the disease, taking a holistic view of health and natural rhythms.
A new study co-led by UT Health San Antonio found that having three or more live births is associated with a reduced risk of stroke and brain damage in women. The research suggests that reproductive factors, such as the number of live births, may be an important predictive factor in assessing stroke risk in women.
The hospital is conducting a phase 2 clinical trial evaluating STAR0602, which activates the immune system to stop tumor growth across various cancers. The goal of this study is to identify safer and more effective treatments for people with advanced cancers.
The UT San Antonio School of Health Professions' Doctor of Physical Therapy program has climbed national rankings due to its five-decade commitment to excellence. The program's curriculum includes clinical affiliations, interprofessional collaborative care, and a selective rotation tailored to student interests.
Researchers at UT Health San Antonio have made a significant breakthrough in treating combat post-traumatic stress disorder (PTSD) by adding navigated TMS to psychotherapy, showing an 85% reduction in symptoms. The study used a patented MRI-guided, robotic-controlled form of transcranial magnetic stimulation (TMS), known as navigated T...
The San Antonio Breast Cancer Symposium generated nearly $40 million in economic impact and drew over 11,000 attendees from 104 countries. The symposium also produced $1.5 million in local tax revenue and supported more than 6,800 jobs.
The program aims to support future pediatric-focused professionals in dentistry, medicine and nursing through competitive scholarships and training. With the gift, UT Health San Antonio will expand access to high-quality care for children and families in Bexar County.
A multi-phase clinical study will examine dosing, safety and long-term effects of rapamycin in older adults to guide future research on extending health span. Researchers aim to establish evidence-based guidance for the drug's use and move beyond speculation.
UT San Antonio has emerged as a unified academic powerhouse, with strong performances in the Blue Ridge Institute for Medical Research rankings. The university has climbed 5 spots to No. 64 among 2,702 institutions, with $147,098,904 in NIH funding, reflecting its commitment to biomedical discovery and research excellence.
The UT Health San Antonio School of Dentistry has secured a $9 million NIH grant to develop a targeted, non-opioid treatment for chronic pain associated with muscle and joint dysfunction. Researchers will map the biology of facial pain, identify specialized neurons, and analyze gene expression changes to design effective treatments.
The Barshop Institute will conduct the VITAL-H trial, evaluating the repurposing of FDA-approved medications to delay age-related health decline in generally healthy middle-aged adults. The trial aims to preserve everyday abilities during a critical window of midlife aging.
A UT Health San Antonio researcher will study how microglia contribute to the spread of toxic tau protein in Alzheimer's disease. The study aims to clarify whether microglia act as barriers or accelerators in the cascade of the disease, potentially leading to new treatments.
The conference aims to improve genetic studies, clinical best practices and community interventions to combat the increasing cancer incidence rates. It will bring together top cancer-focused minds to promote precision medicine and stimulate multidisciplinary collaborations for cancer solutions.
The Biggs Institute will focus on finding solutions to dementia through advanced research, therapies, and care. The new precision therapy center will be named after the donors.
Post-stroke spasticity affects an estimated 30-80% of stroke survivors, causing abnormal muscle tightness and involuntary spasms. Earlier diagnosis and timely intervention may improve functional outcomes and reduce long-term disability, according to the new scientific statement.
A new study led by Dr. Chu Chen suggests that combining THC with celecoxib may improve cognition and reduce Alzheimer's-related brain pathology in mice. The combination produced better outcomes than low-dose THC alone, including improved learning and memory performance and reduced markers of neuroinflammation.
Researchers seek to improve burn trauma care by targeting a signaling kinase enzyme with a new-generation inhibitor. The goal is to reduce opioids needed for pain relief and scarring, improving patient recovery from trauma injury.
The new program combines limb preservation, amputation care, and reconstructive solutions like osseointegration to improve identity, functional outcome, and quality of life for patients. Patients will receive coordinated, personalized, and expert care that supports their recovery and promotes sustained overall health.
UT Health San Antonio received $3 million in CPRIT grants to expand access to preventive salpingectomy, test novel methods to prevent liver cancer, and advance treatment for therapy-resistant metastatic breast cancer. These projects aim to improve cancer prevention, diagnosis, and treatment in South Texas.
Researchers at UT Health San Antonio are developing APOBEC inhibitors to block tumor mutation rates and slow cancer's evolution. The goal is to strengthen current therapies and improve their long-term effectiveness.
The University of Texas at San Antonio has received a $30 million gift from the Kate Marmion Charitable Foundation to support public health initiatives. The gift will address health challenges in South Texas, including obesity and limited access to healthcare.
Researchers at UT Health San Antonio successfully used radiofrequency ablation to treat a patient with pancreatic cancer, achieving the first-ever less-invasive procedure in South Texas. The treatment has shown promising results in shrinking tumors and easing symptoms, potentially improving patient outcomes.
The UT Health San Antonio Center for Brain Health brings together expertise in dozens of disorders, emphasizing education, family support and community connection. The center is part of ongoing national research initiatives, including a study on ALS and HEALEY ALS Platform Trial.
The 48th San Antonio Breast Cancer Symposium brings together over 10,000 global experts to share cutting-edge research on breast cancer discovery, therapeutics, and standard of care. Key findings include the effectiveness of active monitoring for low-risk DCIS patients and a new estrogen-blocking pill that slows cancer progression.
Researchers are investigating training caregivers on ear acupressure to help alleviate chronic pain in people with dementia. The one-year initiative aims to recruit 30-40 participants, plus caregivers, and assess the feasibility and acceptability of this non-pharmacological technique.
A five-year NIH-funded study will explore the role of glucagon hormone in human metabolism, focusing on its impact on insulin secretion, glucose regulation, and energy balance. The research aims to clarify glucagon's function and inform more effective drug development for obesity and Type 2 diabetes treatment.
Researchers aim to strengthen and retrain swallowing function in people with early Parkinson's disease using a novel treatment program. The three-year study will test the effectiveness of SwallowFIT on swallowing difficulties, aspiration rates and nutritional status.
Researchers from UT Health San Antonio discovered that changes in brain fats play a major role in Alzheimer's development and progression. Targeting microglia, the brain's immune cells, may help restore balance and support brain health. Progranulin levels also emerged as a key lipid regulator.
The UT Health San Antonio Center for Brain Health is a $100 million facility that brings together clinical care, diagnostics and research under one roof. The center will redefine treatment of conditions including Alzheimer's, dementia, stroke and Parkinson's with multidisciplinary care teams.
Researchers found a link between platelet aggregation and Alzheimer's biomarkers in midlife, suggesting a potential early warning sign. The study analyzed 382 participants and found that stronger platelet clumping was associated with higher levels of amyloid and tau proteins.
The updated guidelines call for structured follow-up, early referral to rehabilitation, and attention to cognitive, mood, and functional changes after TBI. Health professionals are urged to screen all TBI patients for health-related social needs, such as food, housing, transportation, and financial insecurity.
Researchers at UT Health San Antonio School of Dentistry are studying novel targets and approaches to treat oral squamous cell carcinoma, the most common type of oral cancer. The studies aim to reduce pain management and mucositis in patients undergoing radiotherapy.
A new study suggests that supplementing with BCAAs alongside an exercise program may help reduce fatigue, improve strength, and ease symptoms of depression for older adults. The research found notable improvements in participants who combined a BCAA supplement with an eight-week exercise program.
The Mays Cancer Center stands among the nation's leading institutions recognized for excellence in cancer care and research. It is one of only four NCI-designated Cancer Centers in Texas, offering specialized programs and delivering comprehensive, multidisciplinary care supported by clinical research.
The UT Health San Antonio Center for Brain Health will unveil a 7-Tesla Terra.X MRI system, providing ultra-high-resolution brain images for diagnosing and studying conditions like dementia and Parkinson's. The technology expands what is possible in research and discovery.
Researchers have identified a risk category called 'pre-prediabetes' that occurs years before standard criteria for prediabetes are met. This stage is characterized by severe insulin resistance and measurable cardiovascular disease, highlighting the need for early detection and treatment.